Alliqua, BSN hammer out deal

Friday, July 8, 2016

YARDLEY, Pa., and CHARLOTTE, N.C. – Alliqua BioMedical, a provider of wound care products, has signed a definitive agreement with BSN Medical for the exclusive distribution rights for its Sorbion, Sachet and Sorbion Sana primary dressings in the U.S., Canada and Latin America. Per the agreement, BSN will pay Alliqua $4.4 million to purchase the rights of Alliqua’s existing distribution agreement with Sorbion GmbH & Co KG, now owned by BSN Medical. “The sale of Alliqua’s exclusive distribution rights for the Sorbion dressing products represents an opportunity for us to add important growth capital to our balance sheet and to focus our future investments on commercializing our own highly differentiated advanced wound care and regenerative technologies,” said David Johnson, CEO of Alliqua.